Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response

Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response

US Patent 7731952 · Granted Jun 8, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeting RNA viruses using inhibitors of METTL32024
Oncolytic herpes simplex virus and therapeutic uses thereof2021
Oncolytic herpes simplex virus and therapeutic uses thereof2021
Method of treatment using oncolytic viruses2021
Oncolytic herpes simplex virus and therapeutic uses thereof2019
Oncolytic herpes simplex virus and therapeutic uses thereof2019
Exogenous tap inhibitor armed oncolytic viruses and therapeutic uses thereof2019
Oncolytic herpes simplex virus and therapeutic uses thereof2018
Oncolytic herpes simplex virus and therapeutic uses thereof2018
Oncolytic herpes simplex virus and therapeutic uses thereof2017
Oncolytic herpes simplex virus and therapeutic uses thereof2017
Avirulent oncolytic herpes simplex virus strains engineered to counter the innat2014